WTR Healthcare Happenings
WTR Healthcare Happenings is a weekly conversation with healthcare executives, medical experts, and investors on recent clinical data or industry-driving events in healthcare.
WTR Healthcare Happenings
Biotech M&A Is Back: What's Driving the 2026 Deal Surge
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode of WTR Healthcare Happenings, host Tim Gerdeman is joined by healthcare equity research analyst Robert Sassoon to discuss the rebound in biotech and pharma M&A. Robert explains why 2026 is shaping up as the strongest M&A environment since 2019, with 35 disclosed-value deals totaling roughly $97 billion in just over six months. The discussion covers rising deal sizes, the patent cliff, a more permissive antitrust backdrop, improved drug-pricing clarity, pharma’s estimated $2.1 trillion in acquisition capacity, and better financing conditions. Tim and Robert also examine the types of clinical-stage assets attracting buyers, key therapeutic areas including oncology, immunology, metabolic disease, CNS, and the growing role of China and AI-driven drug discovery in the next wave of transactions.